320 related articles for article (PubMed ID: 32739118)
41. Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.
Cao W; Kim JH; Reber AJ; Hoelscher M; Belser JA; Lu X; Katz JM; Gangappa S; Plante M; Burt DS; Sambhara S
Vaccine; 2017 Jun; 35(25):3318-3325. PubMed ID: 28499553
[TBL] [Abstract][Full Text] [Related]
42. Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge.
Tomar J; Patil HP; Bracho G; Tonnis WF; Frijlink HW; Petrovsky N; Vanbever R; Huckriede A; Hinrichs WLJ
J Control Release; 2018 Oct; 288():199-211. PubMed ID: 30218687
[TBL] [Abstract][Full Text] [Related]
43. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
[TBL] [Abstract][Full Text] [Related]
44. Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine.
Ju Y; Fan H; Liu J; Hu J; Li X; Li C; Chen L; Gao Q; Gao GF; Meng S
Vaccine; 2014 May; 32(23):2703-11. PubMed ID: 24699472
[TBL] [Abstract][Full Text] [Related]
45. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
[TBL] [Abstract][Full Text] [Related]
46. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
[TBL] [Abstract][Full Text] [Related]
47. Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine.
Zhou Y; Li S; Bi S; Li N; Bi Y; Liu W; Wang B
Int Immunopharmacol; 2020 Jan; 78():106013. PubMed ID: 31806571
[TBL] [Abstract][Full Text] [Related]
48. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
[TBL] [Abstract][Full Text] [Related]
49. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
[TBL] [Abstract][Full Text] [Related]
50. Induction of lung CD8
Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
[TBL] [Abstract][Full Text] [Related]
51. Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant.
Ainai A; Tashiro M; Hasegawa H
Hum Vaccin; 2011; 7 Suppl():174-82. PubMed ID: 21321485
[TBL] [Abstract][Full Text] [Related]
52. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
[TBL] [Abstract][Full Text] [Related]
53. Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.
Wu CY; Chang CY; Ma HH; Wang CW; Chen YT; Hsiao PW; Chang CC; Chan CH; Liu CC; Chen JR
Vaccine; 2014 Jul; 32(35):4485-4494. PubMed ID: 24962757
[TBL] [Abstract][Full Text] [Related]
54. Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.
Dehghan S; Tafaghodi M; Bolourieh T; Mazaheri V; Torabi A; Abnous K; Tavassoti Kheiri M
Int J Pharm; 2014 Nov; 475(1-2):1-8. PubMed ID: 25148732
[TBL] [Abstract][Full Text] [Related]
55. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
Sekiya T; Mifsud EJ; Ohno M; Nomura N; Sasada M; Fujikura D; Daito T; Shingai M; Ohara Y; Nishimura T; Endo M; Mitsumata R; Ikeda T; Hatanaka H; Kitayama H; Motokawa K; Sobue T; Suzuki S; Itoh Y; Brown LE; Ogasawara K; Kino Y; Kida H
Vaccine; 2019 Apr; 37(15):2158-2166. PubMed ID: 30857932
[TBL] [Abstract][Full Text] [Related]
56. Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.
Karlsson I; Borggren M; Nielsen J; Christensen D; Williams J; Fomsgaard A
Hum Vaccin Immunother; 2017 Aug; 13(8):1823-1830. PubMed ID: 28613978
[TBL] [Abstract][Full Text] [Related]
57. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
[TBL] [Abstract][Full Text] [Related]
58. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection.
Honda-Okubo Y; Kolpe A; Li L; Petrovsky N
Vaccine; 2014 Aug; 32(36):4651-9. PubMed ID: 24958701
[TBL] [Abstract][Full Text] [Related]
59. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
60. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.
Kopecky-Bromberg SA; Fraser KA; Pica N; Carnero E; Moran TM; Franck RW; Tsuji M; Palese P
Vaccine; 2009 Jun; 27(28):3766-74. PubMed ID: 19464560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
